Conference Menu

Overview
Day 1
Day 2
Register
Poster
Download PDF
Hotel & Travel
Sponsor/Exhibit
 

Don't Miss!
Biomarkers Europe
8-10 November 2006
Vienna, Austria

 

Corporate Sponsor:

 

Corporate Donor:

 

Lead
Sponsoring Publications:

 

Sponsoring Publications:

 

 

Web Partner:

 


Overview


Comprehensive Coverage of Protein Biomarker Technologies and Applications:
• Advances in FT-ICR-MS for Biomarker Discovery
• Biomarker Identification from Complex Mixtures
• Protein Microarrays for Biomarker Discovery
• Cancer Biomarkers
• From Protein Biomarkers to Clinical Diagnostics
• Biomarkers to Predict Response to Therapy
• Post-Translational Modifications as Biomarkers
• Proteomic Data Analysis for Biomarker Identification


Distinguished Faculty:

Christoph H. Borchers, Ph.D., Department of Biochemistry and Microbiology, Director, University of Victoria - Genome British Columbia Proteomics Centre

Walter Carney, Ph.D., President, Oncogene Science, Biomarker Development, Bayer Healthcare

Brian T. Edmonds, Ph.D., Principal Investigator, Manager New Technologies, Integrative Biology & Global Discovery Research, Eli Lilly & Co.

Thomas M. Grogan, M.D., Professor of Pathology, University of Arizona and Chief Scientific Officer, Ventana Medical Systems, Inc.

John Haley, Ph.D., Senior Fellow, Translational Research, OSI Pharmaceuticals Inc.

Ronald C. Hendrickson, Ph.D., Director, MP Proteomics, Merck Research Labs

Marina Hincapie, Ph.D., Principal Research Investigator, The Barnett Institute of Chemical and Biological Sciences, Northeastern University

Djuro Josic, Ph.D., Professor, Medicine (Research), Brown Medical School, Director, Proteomics Core, COBRE Center for Cancer Research Development, Rhode Island Hospital

Elise C. Kohn, M.D., Head, Molecular Signaling Section, Principal Investigator, Laboratory of Pathology, NCI

Brian Liu, Ph.D., Assistant Professor of Urology, Director of Translational Research in Urology, Brigham and Women’s Hospital, Harvard Medical School

David M. Lubman, Ph.D., Maude T. Lane Professor of Surgery and Professor of Pathology and Chemistry, University of Michigan

Brian Luke, Ph.D., Senior Scientist, Advanced Biomedical Computing Center, SAIC-Frederick/NCI

Gary Means, Ph.D., Principal Scientist, Molecular Sciences, Amgen Corp.

Alexey I. Nesvizhskii, Ph.D., Assistant Professor, Department of Pathology, University of Michigan

Jeffrey S. Patrick, Ph.D., Integrative Biology, Biomarkers, Eli Lilly & Co.

Wayne F. Patton, Ph.D., Director of Biochemistry, PerkinElmer Life and Analytical Sciences

Emanuel F. Petricoin, Ph.D., Co-Director, Center for Applied Proteomics and Molecular Medicine, Chair, Department of Molecular and Microbiology, George Mason University

Joel Pounds, Ph.D., Senior Staff Scientist, Cell Biology & Biochemistry, Biological Sciences Division; Science Advisor, Environmental Biomarkers Initiative, Pacific Northwest National Laboratory 

Fred Regnier, Ph.D., J.H. Law Distinguished Professor, Department of Chemistry, Purdue University

David W. Speicher, Ph.D., Professor & Chair, Systems Biology Division; Director, Proteomics Laboratory, The Wistar Institute

Michael Tainsky, Ph.D., Professor, Molecular Biology, Karmanos Cancer Institute

Jennifer Van Eyk, Ph.D., Director, The Hopkins NHLBI Proteomics Center, Director, Bayview Proteomics Group, Associate Professor Medicine, Division of Cardiology, Biological Chemistry and Biomedical Engineering, Johns Hopkins University

Jing Wei, Ph.D., Senior Scientist, Biological Mass Spec, Biogen Idec

Hear what past attendees have to say:

"CHI’s Protein Biomarkers was a highlight of the year for Bayer–the visibility and networking opportunities were unparalleled."
–Marcia L., Director, Genomics and Bioinformatics, Bayer Diagnostics

"This was not a basic review meeting. Real leaders discussed real issues."
–Stephen W., Executive Director & Worldwide Head of Clinical Technology, Pfizer Inc.

"A comprehensive synthesis of where the field of protein biomarkers is today and a good predictor of where it is headed."
–Federico G., R&D Fellow, Schering-Plough Research Institute

"As usual, CHI anticipated emerging aspects of proteomics and biomarkers in scheduling this meeting, recruiting speakers, and attracting excellent and active participants."
–Gilbert O., University of Michigan